Searching for the ideal cancer vaccine.
D017951:Antigen Presentation / Q000276:immunology; D000951:Antigens, Neoplasm / Q000235:genetics / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006360:Heat-Shock Proteins / Q000276:immunology; D006460:Hemolysin Proteins / Q000276:immunology; D049674:History, 21st Century; D006801:Humans; D007113:Immunity, Innate; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D001427:Bacterial Toxins; D019496:Cancer Vaccines; D006360:Heat-Shock Proteins; D006460:Hemolysin Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D011993:Recombinant Fusion Proteins; D014020:Tissue Extracts; C511774:sipuleucel-T; C508053:ERBB2 protein, human; C038705:hlyA protein, Listeria monocytogenes